Yushin Company (6482) Q2 2026 earnings summary

Executive summary

• Net sales for the first half of FY2026 declined 12.4% year-over-year to 10,629 million yen, mainly due to a sharp drop in custom-ordered equipment sales for the medical sector, despite robust robot sales in Asia and growth in Asia overall.

• Operating profit fell 83.8% year-over-year to 147 million yen, impacted by lower sales, higher personnel costs from proactive human capital investments, and increased R&D expenses.

• Profit attributable to owners of parent dropped 78.4% year-over-year to 115 million yen.

• The company is maintaining its annual dividend forecast at 20 yen per share and plans a share repurchase up to 1 billion yen to enhance shareholder returns.

Financial highlights

• First half FY2026 net sales: 10,629 million yen (down 12.4% year-over-year); full-year forecast: 23,000 million yen (down 12.0%).

• Operating profit: 147 million yen (down 83.8% year-over-year); full-year forecast: 1,500 million yen (down 42.0%).

• Ordinary profit: 163 million yen (down 77.9% year-over-year); full-year forecast: 1,500 million yen (down 40.8%).

• Profit attributable to owners of parent: 115 million yen (down 78.4% year-over-year); full-year forecast: 1,000 million yen (down 40.9%).

• Gross profit decreased to 4,148 million yen from 4,895 million year-over-year; gross margin for the first half: 39.0% (down from 40.3%).

Outlook and guidance

• Net sales and operating profit are expected to decline for the full year due to continued weak demand for custom-ordered medical equipment and uncertain capital investment trends, especially in Europe.

• Automation demand is anticipated to persist over the medium to long term, driven by labor shortages.

• The company aims to improve productivity and reduce costs to offset sales declines.

• Dividend forecast maintained at 20 yen per share for FY2026.